NAMPT and neoplasm: Importantly, in vivo administration of the new NAMPT inhibitors as a single agent prevented and/or delayed tumor growth in an animal model of human Burkitt lymphoma and significantly prolonged median survival, thereby underlining the therapeutic potential of these molecules.